Cart
sales@molnova.com
Asymmetric dimethylarginine
CAS No. 30315-93-6
Asymmetric dimethylarginine( —— )
Catalog No. M20947 CAS No. 30315-93-6
Asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase (NOS).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 37 | Get Quote |
|
| 10MG | 51 | Get Quote |
|
| 25MG | 91 | Get Quote |
|
| 50MG | 118 | Get Quote |
|
| 100MG | 153 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAsymmetric dimethylarginine
-
NoteResearch use only, not for human use.
-
Brief DescriptionAsymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase (NOS).
-
DescriptionAsymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthase (NOS).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNF-κB
-
TargetNOD
-
RecptorNO synthesis|Human Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number30315-93-6
-
Formula Weight202.25
-
Molecular FormulaC8H18N4O2
-
Purity>98% (HPLC)
-
SolubilityH2O:100 mg/mL (494.44 mM; adjust pH to 2-3 with HCl)
-
SMILESCN(C)C(=N)NCCC[C@H](N)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Anna M Wieczór Rados?aw Wieczór Arleta Kulwas et al.Asymmetric Dimethylarginine and Angiogenesis: Biological Significance[J]Int Angiol 37 (6) 431-436 Dec 2018
molnova catalog
related products
-
Procyanidin B2
Procyanidin B2 has vascular protective anti-diabetic nephropathy anti-cancer anti-inflammatory and antioxidant activities. Procyanidin B2 inhibited NLRP3 inflammasome activation via suppression of AP-1 pathway.
-
NT-0249
NT-0249 is an orally active inhibitor of the inflammatory vesicle NLRP3 with anti-inflammatory activity that reverses high-fat diet-induced obesity, systemic inflammation, and astrocyte hyperplasia.
-
ADS032
ADS032 (BT-032) is an NLRP1 and NLRP3 inhibitor with anti-inflammatory activity,, inhibits the activation of NLRP1 and NLRP3, inhibits Nigericin-induced IL-1β production, and can be used to study respiratory inflammation or infection.
